Drug Profile
Research programme: anticancer therapeutics - S*BIO/A*STAR
Latest Information Update: 12 Aug 2010
Price :
$50
*
At a glance
- Originator Agency for Science, Technology and Research; S*BIO
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 07 Feb 2007 Early research in Cancer in Singapore (unspecified route)